TMCnet News
Bharat Book Bureau: PharmaPoint: Dermatophytic Onychomycosis (DO) - US Drug Forecast and Market Analysis to 2022(M2 PressWIRE Via Acquire Media NewsEdge) Summary Dermatophytic onychomycosis (DO) is characterized as being a fungal infection of the nail. Infection can involve the nail unit (nail matrix, nail bed, or nail plate). DO isn't considered life-threatening, however can cause patients to experience discomfort, pain, and may cause physical and occupational limitations. DO patients can be identified as having thick or brittle nails along with discoloration (white and opaque). Physicians currently use direct microscopy and fungal culture tests to ensure correct diagnosis and treatment are achieved. Risk factors such as advanced age, pre-existing diabetes, or immunocompromised systems can increase the incidence of DO in patients. Current therapies consist of generics that offer substantial efficacy but sub-par safety profiles. A new wave of therapies is expected to offer topical options for patients who are unable to withstand existing generic options. These therapies are also expected to drive an increase in total drug treatment rates in the US market. Highlights Key Questions Answered - How big of an impact will topical agents have on the DO market? What do key opinion leaders think of this paradigm shift? - What new product is expected to become the market leader during the forecast period? How will this impact the existing generic therapies? - How will a change in the route of administration change the uptake of drugs in the US market? - What are the primary unmet needs that exist in the market according to key opinion leaders? - What alliance opportunities exist in this market for a company looking to tap into the DO market? For more info: https://www.bharatbook.com/healthcare-market-research-reports-407571/drugs-healthcare-united-states-.html Contact us at : Bharat Book Bureau Tel: +91 22 27810772+91 22 27810772 / 27810773 Toll Free No for USA/Canada : 1-866-279-83681-866-279-8368 Email: [email protected] Website: www.bharatbook.com Follow us on twitter: https://twitter.com/researchbook Follow us on linked in : http://www.linkedin.com/company/bharat-book-bureau Our Blog : http://blog.bharatbook.com/CallSend SMSAdd to SkypeYou'll need Skype CreditFree via Skype . (c) 2014 M2 COMMUNICATIONS [ Back To TMCnet.com's Homepage ] |